Aggressive Lymphomas
News
Access to care drives disparity between urban, rural cancer patients
New research suggests that better access to quality care may reduce disparities in survival between cancer patients living in rural areas of the...
From the Journals
Meta-analysis supports rituximab maintenance in MCL
Rituximab maintenance therapy prolonged progression-free survival. Risk of grade 3 or 4 neutropenia was increased, but risk of infection was not...
News
Real-world bleeding risk with ibrutinib
The Bruton tyrosine kinase inhibitor ibrutinib has been linked to a 20-fold increased risk of major bleeding in blood cancer patients taking...
Feature
Phase 1 CAR T trial for NHL launches in Cleveland
The trial will enroll 12-15 adult patients with non-Hodgkin lymphoma who have not responded to standard therapies.
From the Journals
Caution urged over real-world bleeding risk with ibrutinib
Ibrutinib was linked to an almost 20-fold increased risk of major bleeding in blood cancer patients taking concomitant antiplatelet and...
News
Auto-HSCT linked to higher AML, MDS risk
Patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) for lymphoma or myeloma have an increased risk of acute myeloid...
News
Group releases new CLL guidelines
Fludarabine, cyclophosphamide, and rituximab are recommended as initial therapy for fit patients with chronic lymphocytic leukemia (CLL) who do...
News
Insurance status linked to survival in FL patients
Having health insurance can mean the difference between life and death for US patients with follicular lymphoma (FL), according to research...
From the Journals
Autotransplant is linked to higher AML, MDS risk
For patients with lymphoma or plasma cell myeloma, autologous hematopoietic cell transplantation was linked to marked increases in the risk of AML...
News
Team recommends melanoma screening in CLL
Patients with chronic lymphocytic leukemia (CLL) should be routinely monitored for melanoma, according to researchers. A study of 470 CLL patients...
News
Frequent BCCs linked to blood cancers
New research suggests people who develop frequent cases of basal cell carcinoma (BCC) have an increased risk of leukemias, lymphomas, and other...